MGUS


Also found in: Dictionary, Thesaurus, Medical.
Related to MGUS: multiple myeloma
AcronymDefinition
MGUSMonoclonal Gammopathy of Undetermined Significance
MGUSMonoclonal Gammopathy of Uncertain Significance
MGUSMonoclonal Gammopathies of Unknown Significance (biomedical science)
MGUSMacroglobulinaemia of Undetermined Significance
References in periodicals archive ?
Combining multiple approaches to detection using one instrument may soon produce a single test screen for MGUS.
Patients with MGUS and smoldering myeloma are followed every 3-6 months without treatment unless there is progression to MM.
Although MGUs are supposed to underwrite risk and leave the pricing to actuaries (or more typically to pricing manuals), in actuality MGUs also make pricing decisions via a mechanism called underwriter's discretion.
Senior study author and NCI investigator Michael Alavanja added: "As several million Americans use pesticides, it's important that the risks of developing MGUS from the use of pesticides is known.
In a single blind randomised control pilot study, curcuminoids or placebo was administered orally, 2 grams twice daily to a cohort of 26 MGUS patients.
call on women who have received silicone implants and have been diagnosed with MGUS, multiple myeloma, or other monoclonal gammopathies to report their diagnosis to the FDA.
whichprovides desktop and mobile insurance software solutions for global insurance carriers and MGUs.
Hooker, speaking from a managing general underwriter perspective, says Bellingham has to differentiate itself in the eyes of insurers, as carriers are scrutinizing MGUs more than in years past.
In NSM, MGUS, primary amyloidosis, and multiple myeloma (7-9) serum FLC, if elevated, can be used as a sensitive marker for monitoring disease, allowing for early identification of relapses and responses without the need for repeated bone marrow biopsies and radiological studies.
Fifty-five respondents, representing approximately 45 carriers and MGUs, took part.
Dresner was promoted to head the company's specialty insurance business unit, where he'll manage programs with MGUs and managing general agencies.
These molecules are then called monoclonal immunoglobulins and are directly related to malignant or potentially malignant disorders such as MM and MGUS.